three more acellular pertussis (DTaP) vaccines for INFANTS
The FDA is close to approving three more acellular pertussis (DTaP) vaccines for INFANTS. Infanrix from SKB...Acel-Imune from Lederle...and Certiva from Abbott.
Tripedia was just approved for infants this summer.
Acel-Imune is already on the market...but so far it's only approved for the fourth and fifth booster doses in children.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote